This information was published on 2019-03-13T20:12:18 for IP Right Acceptance Published.
| Field | Value |
| (210) | 1951419 |
| (220) |
28 Aug 2018
|
| (511) (510) |
Class 5
Human pharmaceuticals for the treatment of immune and inflammatory diseases and disorders |
| (540) | ONE-PRESS |
| (550) | Word |
| (730) |
Johnson & Johnson
|
| (750) |
Shelston IP Pty Ltd.
|
Find out more about publications on the About page.